AU5029293A - Novel technetium and rhenium binding bivalent haptens, application to in vivo diagnostic and therapeutics, kits and immunological reagents used in combination - Google Patents

Novel technetium and rhenium binding bivalent haptens, application to in vivo diagnostic and therapeutics, kits and immunological reagents used in combination

Info

Publication number
AU5029293A
AU5029293A AU50292/93A AU5029293A AU5029293A AU 5029293 A AU5029293 A AU 5029293A AU 50292/93 A AU50292/93 A AU 50292/93A AU 5029293 A AU5029293 A AU 5029293A AU 5029293 A AU5029293 A AU 5029293A
Authority
AU
Australia
Prior art keywords
therapeutics
application
kits
combination
immunological reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU50292/93A
Other versions
AU669219B2 (en
Inventor
Jacques Barbet
Michel Delaage
Anne Gruaz-Guyon
Jean-Marc Le Doussal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunotech SAS
Original Assignee
Immunotech Partners SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech Partners SA filed Critical Immunotech Partners SA
Publication of AU5029293A publication Critical patent/AU5029293A/en
Application granted granted Critical
Publication of AU669219B2 publication Critical patent/AU669219B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Derivatives comprising two hydrophilic haptens and a potentially effector group of general formula <IMAGE> and their salts, in which X represents a hydrogen atom or a protective group which can be used for protecting a thiol functional group against oxidation (CH3CO- or C6H5CO- radical), R1, R2 and R3 each represent an amino acid and H1 and H2 represent hydrophilic haptens; process of preparation; application in diagnosis and in therapeutics, diagnostic or therapeutic kits and immunological reagents containing them. <IMAGE>
AU50292/93A 1992-10-27 1993-10-26 Novel technetium and rhenium binding bivalent haptens, application to in vivo diagnostic and therapeutics, kits and immunological reagents used in combination Ceased AU669219B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9213267 1992-10-27
FR9213267A FR2697255B1 (en) 1992-10-27 1992-10-27 New bihapten derivatives linking technetium, application to diagnosis and therapy, kits and immunological reagents using them.

Publications (2)

Publication Number Publication Date
AU5029293A true AU5029293A (en) 1994-05-12
AU669219B2 AU669219B2 (en) 1996-05-30

Family

ID=9435217

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50292/93A Ceased AU669219B2 (en) 1992-10-27 1993-10-26 Novel technetium and rhenium binding bivalent haptens, application to in vivo diagnostic and therapeutics, kits and immunological reagents used in combination

Country Status (11)

Country Link
EP (1) EP0595743B1 (en)
JP (1) JPH06321809A (en)
KR (1) KR940009209A (en)
AT (1) ATE199728T1 (en)
AU (1) AU669219B2 (en)
CA (1) CA2109256C (en)
DE (1) DE69330019T2 (en)
DK (1) DK0595743T3 (en)
ES (1) ES2155830T3 (en)
FR (1) FR2697255B1 (en)
GR (1) GR3036012T3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039180A1 (en) * 1995-06-06 1996-12-12 Abbott Laboratories Immunogen preparation with hapten
FR2816620B1 (en) * 2000-11-16 2003-02-21 Inst Nat Sante Rech Med NOVEL COMPOUNDS FOR APPLICATIONS TO RADIOIMMUNOSCINTINGRAPHY AND / OR RADIOIMMUNOTHERAPY OF CANCERS
US20210017180A1 (en) 2018-03-30 2021-01-21 Centre National De La Recherche Scientifique Pyclen-based macrocyclic ligands, chelates thereof and uses thereof
EP4273142A1 (en) 2022-05-06 2023-11-08 Université de Bretagne Occidentale Picolinate cyclam palladium chelates and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652004B1 (en) * 1989-09-21 1994-10-28 Immunotech Partners NOVEL HYDROPHILIC DERIVATIVES, APPLICATION TO DIAGNOSIS AND THERAPEUTICS, DIAGNOSTIC OR THERAPEUTIC KITS AND IMMUNOLOGICAL REAGENTS.

Also Published As

Publication number Publication date
DE69330019T2 (en) 2001-09-06
FR2697255A1 (en) 1994-04-29
GR3036012T3 (en) 2001-09-28
EP0595743A1 (en) 1994-05-04
EP0595743B1 (en) 2001-03-14
DK0595743T3 (en) 2001-07-09
CA2109256C (en) 2004-06-15
FR2697255B1 (en) 1995-01-13
ATE199728T1 (en) 2001-03-15
DE69330019D1 (en) 2001-04-19
KR940009209A (en) 1994-05-20
CA2109256A1 (en) 1994-04-28
ES2155830T3 (en) 2001-06-01
AU669219B2 (en) 1996-05-30
JPH06321809A (en) 1994-11-22

Similar Documents

Publication Publication Date Title
GR3018387T3 (en) Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them.
GR3024686T3 (en) Novel guinolone and naphthyridone derivatives.
AU7137491A (en) New aminomethylpiperidine derivatives, process for preparing these and pharmaceutical compositions containing them
AU581442B2 (en) 2-substituted-1, 3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
DE69020781T2 (en) Bile acid derivatives, process for their preparation and pharmaceutical compositions thereof.
AU5029293A (en) Novel technetium and rhenium binding bivalent haptens, application to in vivo diagnostic and therapeutics, kits and immunological reagents used in combination
NO974165L (en) Preparation of N-arylmethyl-aziridine derivatives, 1,4,7,10-tetraazacyclododecane derivatives prepared therefrom and N-arylmethyl-ethanolamine sulfonate esters as intermediates
ATE93863T1 (en) ENZYME INHIBITING AMINO ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION, COMPOSITIONS THEREOF AND THEIR USE.
HK56597A (en) 3-aminochromane derivatives procedure for their preparation and pharmaceutical compositions containing them
ATE63921T1 (en) 6-AMINO-ANTHRACYCLINES, PROCESSES FOR THEIR PREPARATION AND USE.
EP0328913A3 (en) Basically substituted 5-halothienoisothiazol-3(2h)-one-1,1-dioxides, process for their preparation and pharmaceutical compositions containing them
ES8503668A1 (en) Diaryl-imidazole compounds, methods for their preparation, pharmaceutical drugs containing them and their use.
DE68922053D1 (en) Pyridoindole derivatives and process for their preparation.
BG103705A (en) Phenoxyacetic acid derivatives and their application as herbicides
EP0387677A3 (en) Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation
Scott-Ennis et al. Differential response of cysteine residues in pig muscle phosphoglucose isomerase to seven sulfhydryl-modifying reagents
IE821204L (en) Quinidine derivatives.
ATE106086T1 (en) UNSATURATED GALLIC ACID DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them